Filter News
Area of Research
News Topics
- (-) Bioenergy (2)
- (-) Cybersecurity (2)
- (-) Isotopes (1)
- (-) Materials Science (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (1)
- Biology (1)
- Biomedical (2)
- Biotechnology (1)
- Buildings (3)
- Chemical Sciences (3)
- Climate Change (2)
- Composites (1)
- Computer Science (2)
- Coronavirus (1)
- Critical Materials (1)
- Decarbonization (7)
- Energy Storage (8)
- Environment (2)
- Grid (4)
- Machine Learning (1)
- Materials (6)
- Microscopy (1)
- National Security (2)
- Net Zero (1)
- Neutron Science (1)
- Nuclear Energy (3)
- Partnerships (4)
- Renewable Energy (1)
- Security (3)
- Simulation (1)
- Summit (1)
- Sustainable Energy (1)
- Transportation (6)
Media Contacts
Four scientists affiliated with ORNL were named Battelle Distinguished Inventors during the lab’s annual Innovation Awards on Dec. 1 in recognition of being granted 14 or more United States patents.
Carl Dukes’ career as an adept communicator got off to a slow start: He was about 5 years old when he spoke for the first time. “I’ve been making up for lost time ever since,” joked Dukes, a technical professional at the Department of Energy’s Oak Ridge National Laboratory.
Scientists studying a valuable, but vulnerable, species of poplar have identified the genetic mechanism responsible for the species’ inability to resist a pervasive and deadly disease. Their finding, published in the Proceedings of the National Academy of Sciences, could lead to more successful hybrid poplar varieties for increased biofuels and forestry production and protect native trees against infection.
As leader of the RF, Communications, and Cyber-Physical Security Group at Oak Ridge National Laboratory, Kerekes heads an accelerated lab-directed research program to build virtual models of critical infrastructure systems like the power grid that can be used to develop ways to detect and repel cyber-intrusion and to make the network resilient when disruption occurs.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.